相关产品推荐更多 >

H1N1 Matrix Protein 1 Rabbit Polyclonal Antibody 抗体,orb5368,Biorbyt
¥3159
POLR2B Antibody - middle region : Biotin 抗体,orb2140072,Biorbyt
¥8216
RENT1/hUPF1 Rabbit Polyclonal Antibody 抗体,orb334574,Biorbyt
¥5499
Thyroid hormone receptor alpha Antibody (AP) 抗体,orb1596346,Biorbyt
¥4796
IKZF2 Antibody 抗体,orb672759,Biorbyt
¥1989
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名:
Claudin 18.2 Recombinant Rabbit Monoclonal Antibody抗体
- 抗体英文名:
Claudin 18.2 Recombinant Rabbit Monoclonal Antibody
- 靶点:
CLDN18
- 浓度:
1mg/ml
- 应用范围:
IF, IHC-Fr, IHC-P
- 宿主:
Rabbit
- 适应物种:
Human, Mouse, Rat
- 保质期:
6-12个月
- 抗原来源:
详询
- 目录编号:
orb1499340
- 级别:
科研级
- 库存:
88
- 供应商:
biorbyt
- 标记物:
Unconjugated
- 克隆性:
Recombinant
- 保存条件:
参考说明书
- 形态:
Liquid
- 亚型:
IgG
- 免疫原:
KLH conjugated synthetic peptide derived from human Claudin-18.2
- 规格:
25 ul
别名:CLD18_HUMAN; Claudin-18; Claudin18; CLDN18; UNQ778/PRO1572; SFTA5; SFTPJ; CLDN18.2; Claudin-18.2; Claudin18.2;
免疫原:KLH conjugated synthetic peptide derived from human Claudin-18.2
预测反应性:Mouse
克隆性:R7G12
分子量:28 kDa
应用稀释比例:IHC-P=1:100-500, IHC-F=1:100-500, IF=1:100-500
防腐剂:0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
纯化:Affinity purified by Protein A
保存说明:Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
UniProt ID:P56856
Note:For research use only.



风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验国产CLDN18.2 ADC申报上市,晚期胃癌靶向治疗迎来新格局
。 华美生物现提供Claudin18.2靶点蛋白和重组抗体等相关产品,加速您的抗体药物开发进程。 部分产品数据展示 Recombinant Human Claudin-18.2(CLDN18.2) (Active) (Mammalian cell) (Full Length) (CSB-MP005498HU(A5) Claudin-18.2 Monoclonal Antibody (CSB-RA005498A1HU) (ELISA, FC
Technology and Production of Murine Monoclonal and Recombinant Antibodies and Antibody Fragments
production described by K�hler and Milstein in 1975 (1 ). In the last 30 yr a number of genetically engineered antibody constructions have emerged, including chimeric and human-like antibodies as well as different antibody fragments. Nowadays, 18 rnAb
In the field of therapeutic recombinant proteins, monoclonal antibodies (mAbs) have achieved a rising success with more than 30 mAbs that have reached the market in the past 20 years. From a structural standpoint, one of the most important
技术资料暂无技术资料 索取技术资料






